Health Care • Industrial Specialties
$5.91 ▲ +0.16
(+2.78%)
MKT CAP: $16.7M • VOL: 1.1K
52W L $4 52W H $10
ROARABLE / RQD
D • 46/100
PIOTROSKI
4 / 9
LFWD // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.4M | $1.7M | $435.0K |
| YoY Revenue Growth % | -17.6% | +290.8% | — |
| Gross Profit | $8.4M | $8.2M | — |
| Gross Margin % | 98.0% | 98.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$19.7M | -$29.3M | -$23.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$19.9M | -$28.9M | -$22.1M |
| EBITDA (Normalized) | -$19.7M | -$29.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$16.8M | -$21.7M | -$20.7M |
| Capital Expenditures (CapEx) | $16.0K | $0 | — |
| Free Cash Flow (FCF) | -$16.8M | -$21.7M | -$20.7M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $2.2M | $6.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $8.4M | $18.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LFWD.